FARO BIDCO APS HAS COMPLETED THE UNREGULATED RECOMMENDED VOLUNTARY OFFER TO THE SHAREHOLDERS OF EVERFUEL A/S
Reading Time: 5 minutes NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, INTO OR WITHIN CANADA, AUSTRALIA, NEW ZEALAND, SOUTH-AFRICA, HONG KONG, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS
Uniqus Consultech Onboards UST as an Investor, as Part of its Previously Announced Series B Round
Reading Time: 3 minutes Aliso Viejo, Calif., United States & Mumbai, Maharashtra, India: UST, a leading digital transformation solutions company, has invested in Uniqus Consultech, a tech-enabled global platform that offers consulting solutions in the accounting & reporting, finance operations, governance, risk, ESG, and technology
BioStock: BiBBInstrument’ founder on the Sahlgrenska evaluation
Reading Time: < 1 minute Tue, Nov 19, 2024 08:15 CET Report this content BiBBInstruments takes another step in the clinical evaluation of EndoDrill GI. Recently, Sahlgrenska University Hospital in Gothenburg joined the growing group of clinics evaluating the instrument. BioStock contacted the
The Ritz-Carlton Leadership Center Announces First Live Virtual Course Offered Globally
Reading Time: 2 minutes Bethesda, Md., United States: Live Virtual Experience Comprises Two-Hour Modules Over Three Consecutive Days: January 13 to 15, 2025 from 8 to 10 pm EST January 14 to 16, 2025 from 9 to 11 am SGT January 14 to 16, 2025
Guidewire Outlines Vision for How Modern Core Platforms will Unlock a New Era of Efficiency and Effectiveness in P&C Insurance
Reading Time: 6 minutes Nashville, Tenn., United States: CONNECTIONS CONFERENCE – Guidewire (NYSE: GWRE) will showcase its commitment to improving risk selection and pricing, indemnity management, and claims efficiency in property and casualty insurance at its annual customer conference, Connections. The event will unveil future
Lytix Biopharma Q3 2024: Positive clinical results and strategic advancements strengthen path to commercialization
Reading Time: 3 minutes Oslo, 19 November 2024. Lytix Biopharma (“Lytix”) (Euronext Growth Oslo: LYTIX), a Norwegian immuno-oncology company dedicated to being part of tomorrow’s cancer treatment, today releases its third quarter 2024 results. Lytix achieved substantial progress in its clinical pipeline, progressing towards
HistoSonics® Enrolls First Patients in Company’s Novel BOOMBOX Master Study
Reading Time: 4 minutes MINNEAPOLIS, United States: HistoSonics, the developer and manufacturer of the Edison® Histotripsy System, announced today the first patients were enrolled in their novel prospective master protocol study, called BOOMBOX, designed to evaluate the real-world use of histotripsy for treatment of liver
Effective Ways to Save Money on Your Utility Bills in Time For Winter
Reading Time: 6 minutes As the colder months approach, it is crucial to take some steps now to reduce your energy consumption and lower your utility bills. By implementing a few simple strategies, you can significantly reduce your energy costs and contribute to a
Kährs confirms that the redemption of its outstanding senior secured sustainability linked floating rate bonds 2021/2026 with ISIN SE0017085285 is no longer conditional
Reading Time: 2 minutes Kährs BondCo AB (publ) (the “Company“) hereby refers to its senior secured sustainability linked floating rate bonds 2021/2026 with ISIN SE0017085285 (the “Bonds“) and to the terms and conditions of the Bonds (the “Terms and Conditions“). Reference is further made to
Nomination Committee appointed for Diagonal Bio
Reading Time: 2 minutes Read original Diagonal Bio today announces that the Nomination Committee has been appointed in preparation for the Annual General Meeting (AGM) on May 20, 2025. According to the instruction for the Nomination Committee adopted by the AGM in 2024, the Nomination